Technical Analysis for THRD - Third Harmonic Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.25 | 0.00% | 0.00 |
THRD closed unchanged on Thursday, January 26, 2023, on 18 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible NR7 | about 10 hours ago |
| Rose Above Previous Day's High | about 11 hours ago |
| 60 Minute Opening Range Breakout | about 13 hours ago |
| Possible Inside Day | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/01/2023
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Mast Cell Immunoglobulin E
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Mast Cell Immunoglobulin E
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.59 |
| 52 Week Low | 3.89 |
| Average Volume | 396,829 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 11.04 |
| 20-Day Moving Average | 4.29 |
| 10-Day Moving Average | 4.33 |
| Average True Range | 0.57 |
| RSI | 24.81 |
| ADX | 49.26 |
| +DI | 12.74 |
| -DI | 37.22 |
| Chandelier Exit (Long, 3 ATRs) | 3.13 |
| Chandelier Exit (Short, 3 ATRs) | 5.75 |
| Upper Bollinger Bands | 4.46 |
| Lower Bollinger Band | 4.13 |
| Percent B (%b) | 0.38 |
| BandWidth | 7.70 |
| MACD Line | -1.66 |
| MACD Signal Line | -2.17 |
| MACD Histogram | 0.5165 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.37 | ||||
| Resistance 3 (R3) | 4.37 | 4.33 | 4.35 | ||
| Resistance 2 (R2) | 4.33 | 4.30 | 4.33 | 4.34 | |
| Resistance 1 (R1) | 4.29 | 4.28 | 4.29 | 4.29 | 4.34 |
| Pivot Point | 4.25 | 4.25 | 4.25 | 4.25 | 4.25 |
| Support 1 (S1) | 4.21 | 4.22 | 4.21 | 4.21 | 4.16 |
| Support 2 (S2) | 4.17 | 4.20 | 4.17 | 4.16 | |
| Support 3 (S3) | 4.13 | 4.17 | 4.15 | ||
| Support 4 (S4) | 4.13 |
